Dual antithrombic therapy with DOAC plus ticagrelor versus DOAC plus clopidogrel after PCI: results from the ReDUAL PCI real life registry-based randomized controlled trial
Dual antithrombic therapy with DOAC plus ticagrelor versus DOAC plus clopidogrel after PCI: results from the ReDUAL PCI real life registry-based randomized controlled trial. // International Journal of Cardiology. – URL: https://www.sciencedirect.com/science/article/pii/S0167527326008570?dgcid=rss_sd_all
Dual antithrombic therapy with DOAC plus ticagrelor versus DOAC plus clopidogrel after PCI: results from the ReDUAL PCI real life registry-based randomized controlled trial. International Journal of Cardiology. https://www.sciencedirect.com/science/article/pii/S0167527326008570?dgcid=rss_sd_all
“Dual antithrombic therapy with DOAC plus ticagrelor versus DOAC plus clopidogrel after PCI: results from the ReDUAL PCI real life registry-based randomized controlled trial.” International Journal of Cardiology.
@article{article49263,
title = {Dual antithrombic therapy with DOAC plus ticagrelor versus DOAC plus clopidogrel after PCI: results from the ReDUAL PCI real life registry-based randomized controlled trial},
journal = {International Journal of Cardiology},
url = {https://www.sciencedirect.com/science/article/pii/S0167527326008570?dgcid=rss_sd_all}
}